Brazil review of Hapvida-Plamed deal dropped after companies withdraw deal
The Brazilian competition authority has dropped its review of healthcare plan operator Hapvida’s planned purchase of rival Plamed after a request by the parties to withdraw the transaction. The deal was...To view the full article, register now.
Already a subscriber? Click here to view full article